Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
0.9913
+0.0401 (4.22%)
Oct 30, 2025, 9:52 AM EDT - Market open
Intelligent Bio Solutions Revenue
In the fiscal year ending June 30, 2025, Intelligent Bio Solutions had annual revenue of $3.05M, down -1.90%. Intelligent Bio Solutions had revenue of $843.88K in the quarter ending June 30, 2025, with 15.95% growth.
Revenue (ttm)
$3.05M
Revenue Growth
-1.90%
P/S Ratio
1.64
Revenue / Employee
$55,501
Employees
55
Market Cap
9.00M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 3.05M | -59.25K | -1.90% |
| Jun 30, 2024 | 3.11M | 1.85M | 147.58% |
| Jun 30, 2023 | 1.26M | - | - |
| Jun 30, 2022 | - | - | - |
| Jun 30, 2021 | 1.98M | 1.79M | 949.30% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
INBS News
- 1 hour ago - Intelligent Bio Solutions Secures 33 New Customer Accounts in the Fiscal 2026 First Quarter, Showing Strong Year-Over-Year Growth and Increasing Total Active Accounts to 480 - GlobeNewsWire
- 7 days ago - Intelligent Bio Solutions Secures Major UK Contract with Multinational Industrial Service Provider - GlobeNewsWire
- 4 weeks ago - Intelligent Bio Solutions Advances Preparations and Provides Updated Timeline for Anticipated FDA 510(k) Submission and Clearance - GlobeNewsWire
- 6 weeks ago - Intelligent Bio Solutions Provides Update on FDA 510(k) Clearance Process for Intelligent Fingerprinting Drug Screening System - GlobeNewsWire
- 2 months ago - Intelligent Bio Solutions Achieves Record Monthly Sales of 12,500+ Units of Higher-Margin Cartridges in July - GlobeNewsWire
- 2 months ago - Intelligent Bio Solutions Reports Fiscal 2025 Fourth Quarter and Full Year Results, Highlighting Progress on Planned U.S. Market Expansion, Revenue Growth and Increased Operational Efficiencies - GlobeNewsWire
- 2 months ago - Intelligent Bio Solutions to Participate in the Sidoti Micro-Cap Virtual Conference on August 20-21, 2025 - GlobeNewsWire
- 3 months ago - Intelligent Bio Solutions Announces Preliminary Fiscal Fourth Quarter Revenue with Double-Digit Sequential and Year-Over-Year Growth and Strong Operational Momentum - GlobeNewsWire